Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

A Data-Driven Approach to Team Training for Nurses in a Level II Trauma Center.

Litzinger TL, Cohen TN, Cabrera JS, Captain KA, Fabian MA, Miles SG, Shappell SA, Boquet AJ.

J Trauma Nurs. 2019 May/Jun;26(3):134-140. doi: 10.1097/JTN.0000000000000438.

PMID:
31483770
2.

Using HFACS-Healthcare to Identify Systemic Vulnerabilities During Surgery.

Cohen TN, Francis SE, Wiegmann DA, Shappell SA, Gewertz BL.

Am J Med Qual. 2018 Nov/Dec;33(6):614-622. doi: 10.1177/1062860618764316. Epub 2018 Mar 21.

PMID:
29562768
3.

A Theoretical Model of Flow Disruptions for the Anesthesia Team During Cardiovascular Surgery.

Boquet A, Cohen T, Diljohn F, Cabrera J, Reeves S, Shappell S.

J Patient Saf. 2017 Jul 3. doi: 10.1097/PTS.0000000000000406. [Epub ahead of print]

PMID:
28678115
4.

Proactive Safety Management in Trauma Care: Applying the Human Factors Analysis and Classification System.

Cohen TN, Cabrera JS, Litzinger TL, Captain KA, Fabian MA, Miles SG, Reeves ST, Shappell SA, Boquet AJ.

J Healthc Qual. 2018 Mar/Apr;40(2):89-96. doi: 10.1097/JHQ.0000000000000094.

PMID:
28671897
5.

Letter to the Editor re: Evaluating the Reliability of the Human Factors Analysis Classification System: Response.

Shappell SA.

Aerosp Med Hum Perform. 2017 Jun 1;88(6):597-598. No abstract available.

PMID:
28539150
6.

Coding Human Factors Observations in Surgery.

Cohen TN, Wiegmann DA, Reeves ST, Boquet AJ, Shappell SA.

Am J Med Qual. 2017 Sep/Oct;32(5):556-562. doi: 10.1177/1062860616675230. Epub 2016 Oct 25.

PMID:
27784757
7.

Using Broken Windows Theory as the Backdrop for a Proactive Approach to Threat Identification in Health Care.

Boquet AJ, Cohen TN, Cabrera JS, Litzinger TL, Captain KA, Fabian MA, Miles SG, Shappell SA.

J Patient Saf. 2016 Sep 9. [Epub ahead of print]

PMID:
27617964
8.

Identifying workflow disruptions in the cardiovascular operating room.

Cohen TN, Cabrera JS, Sisk OD, Welsh KL, Abernathy JH, Reeves ST, Wiegmann DA, Shappell SA, Boquet AJ.

Anaesthesia. 2016 Aug;71(8):948-54. doi: 10.1111/anae.13521.

9.

Evaluating the Reliability of the Human Factors Analysis and Classification System.

Cohen TN, Wiegmann DA, Shappell SA.

Aerosp Med Hum Perform. 2015 Aug;86(8):728-35. doi: 10.3357/AMHP.4218.2015. Review.

PMID:
26387897
10.

Human factors analysis of a near-miss event: oxygen supply failure during cardiopulmonary bypass.

Spiess BD, Rotruck J, McCarthy H, Suarez-Wincosci O, Kasirajan V, Wahr J, Shappell S.

J Cardiothorac Vasc Anesth. 2015 Feb;29(1):204-9. doi: 10.1053/j.jvca.2014.08.011. Epub 2014 Dec 4. Review. No abstract available.

PMID:
25481389
11.

Reply: To PMID 25443926.

Brown JG, Rigler W, Shappell SB.

Urology. 2014 Nov;84(5):1179-80. doi: 10.1016/j.urology.2014.05.077. Epub 2014 Oct 24. No abstract available.

PMID:
25443930
12.

Reply: To PMID 25443926.

Brown JG, Shappell SB.

Urology. 2014 Nov;84(5):1178. doi: 10.1016/j.urology.2014.05.076. Epub 2014 Oct 24. No abstract available.

PMID:
25443928
13.

Reflex PCA3 messenger ribonucleic acid testing: validation of postbiopsy urine samples and correlation with prostate biopsy findings in ∼2000 patients.

Brown JG, Fulmer JR, Romano J, Pownell J, Rigler W, Wirtshafter A, Sarno M, Shappell SB.

Urology. 2014 Nov;84(5):1172-80. doi: 10.1016/j.urology.2014.05.067. Epub 2014 Oct 24.

PMID:
25443926
14.

Patient safety in the cardiac operating room: human factors and teamwork: a scientific statement from the American Heart Association.

Wahr JA, Prager RL, Abernathy JH 3rd, Martinez EA, Salas E, Seifert PC, Groom RC, Spiess BD, Searles BE, Sundt TM 3rd, Sanchez JA, Shappell SA, Culig MH, Lazzara EH, Fitzgerald DC, Thourani VH, Eghtesady P, Ikonomidis JS, England MR, Sellke FW, Nussmeier NA; American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research.

Circulation. 2013 Sep 3;128(10):1139-69. doi: 10.1161/CIR.0b013e3182a38efa. Epub 2013 Aug 5. Review. No abstract available. Erratum in: Circulation. 2013 Sep 17;128(12):e192.

PMID:
23918255
15.

The Human Factors Analysis Classification System (HFACS) applied to health care.

Diller T, Helmrich G, Dunning S, Cox S, Buchanan A, Shappell S.

Am J Med Qual. 2014 May-Jun;29(3):181-90. doi: 10.1177/1062860613491623. Epub 2013 Jun 27.

PMID:
23814026
16.

Realizing improved patient care through human-centered operating room design: a human factors methodology for observing flow disruptions in the cardiothoracic operating room.

Palmer G 2nd, Abernathy JH 3rd, Swinton G, Allison D, Greenstein J, Shappell S, Juang K, Reeves ST.

Anesthesiology. 2013 Nov;119(5):1066-77. doi: 10.1097/ALN.0b013e31829f68cf.

PMID:
23811697
17.

Editorial comment.

Shappell SB.

Urology. 2011 Nov;78(5):1119; author reply 1120. doi: 10.1016/j.urology.2011.05.055. No abstract available.

PMID:
22054383
18.

Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence.

Salem S, Chang SS, Clark PE, Davis R, Herrell SD, Kordan Y, Wills ML, Shappell SB, Baumgartner R, Phillips S, Smith JA Jr, Cookson MS, Barocas DA.

J Urol. 2010 Oct;184(4):1334-40. doi: 10.1016/j.juro.2010.06.041. Epub 2010 Aug 17.

PMID:
20723932
19.

Operator error and system deficiencies: analysis of 508 mining incidents and accidents from Queensland, Australia using HFACS.

Patterson JM, Shappell SA.

Accid Anal Prev. 2010 Jul;42(4):1379-85. doi: 10.1016/j.aap.2010.02.018. Epub 2010 Apr 1.

PMID:
20441855
20.

Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.

Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW.

PLoS One. 2009 Dec 21;4(12):e8384. doi: 10.1371/journal.pone.0008384.

21.

Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW.

Cell Death Differ. 2010 Mar;17(3):469-81. doi: 10.1038/cdd.2009.148. Epub 2009 Oct 16.

22.

Identification of extracellular delta-catenin accumulation for prostate cancer detection.

Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA, Frelix G, Shappell S, Chen YH.

Prostate. 2009 Mar 1;69(4):411-8. doi: 10.1002/pros.20902.

23.

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.

Shappell SB, Fulmer J, Arguello D, Wright BS, Oppenheimer JR, Putzi MJ.

Urology. 2009 Feb;73(2):363-8. doi: 10.1016/j.urology.2008.08.459. Epub 2008 Nov 8.

PMID:
18995890
24.
25.

Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.

Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB.

J Urol. 2008 May;179(5 Suppl):S27-32. doi: 10.1016/j.juro.2008.03.134.

PMID:
18405745
26.

Bioluminescence imaging of vascular endothelial growth factor promoter activity in murine mammary tumorigenesis.

Faley SL, Takahashi K, Crooke CE, Beckham JT, Tomemori T, Shappell SB, Jansen ED, Takahashi T.

Mol Imaging. 2007 Sep-Oct;6(5):331-9.

PMID:
18092518
27.

Human error and commercial aviation accidents: an analysis using the human factors analysis and classification system.

Shappell S, Detwiler C, Holcomb K, Hackworth C, Boquet A, Wiegmann DA.

Hum Factors. 2007 Apr;49(2):227-42.

PMID:
17447665
28.
29.
30.

Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy.

Girasole CR, Cookson MS, Putzi MJ, Chang SS, Smith JA Jr, Wells N, Oppenheimer JR, Shappell SB.

J Urol. 2006 Mar;175(3 Pt 1):929-33; discussion 933.

PMID:
16469583
31.

Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.

Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen YH.

Hum Pathol. 2005 Oct;36(10):1037-48. Epub 2005 Sep 6.

PMID:
16226102
32.

Expression and role of Foxa proteins in prostate cancer.

Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, Matusik RJ.

Prostate. 2006 Jul 1;66(10):1013-28.

PMID:
16001449
33.

Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.

Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ.

Development. 2005 Aug;132(15):3431-43. Epub 2005 Jun 29.

34.

Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.

Ishii K, Shappell SB, Matusik RJ, Hayward SW.

Lab Invest. 2005 Sep;85(9):1086-103.

35.

Detection and subcellular localization of two 15S-lipoxygenases in human cornea.

Chang MS, Schneider C, Roberts RL, Shappell SB, Haselton FR, Boeglin WE, Brash AR.

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):849-56.

PMID:
15728540
36.

Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB.

Neoplasia. 2004 Nov-Dec;6(6):821-30.

37.

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue.

Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, Xue H, Sadar M, Shappell SB, Cunha GR, Hayward SW.

Prostate. 2005 Jul 1;64(2):149-59.

PMID:
15678503
38.

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.

Cancer Res. 2004 Aug 1;64(15):5489-95.

39.

15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation.

Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y, Shappell SB.

Hum Pathol. 2004 Jul;35(7):840-9.

PMID:
15257547
40.

Adverse prognostic significance of capsular incision with radical retropubic prostatectomy.

Shuford MD, Cookson MS, Chang SS, Shintani AK, Tsiatis A, Smith JA Jr, Shappell SB.

J Urol. 2004 Jul;172(1):119-23.

PMID:
15201750
41.

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD.

Cancer Res. 2004 Mar 15;64(6):2270-305. Review.

42.

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.

Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL.

Science. 2004 Feb 6;303(5659):848-51.

43.
44.

Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.

Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB.

J Urol. 2004 Feb;171(2 Pt 1):646-51.

PMID:
14713778
45.

An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line.

Masumori N, Tsuchiya K, Tu WH, Lee C, Kasper S, Tsukamoto T, Shappell SB, Matusik RJ.

J Urol. 2004 Jan;171(1):439-42.

PMID:
14665950
46.

Primary renal carcinoid tumor.

Cole EE, DeSouza R, Shappell S, Cookson MS.

J Urol. 2004 Jan;171(1):338. Review. No abstract available.

PMID:
14665914
47.

The loss of TGF-beta signaling promotes prostate cancer metastasis.

Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ.

Neoplasia. 2003 May-Jun;5(3):267-77. doi: 10.1016/S1476-5586(03)80058-1.

48.

Monoclonal gammopathy: significance and possible causality in renal disease.

Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB.

Am J Kidney Dis. 2003 Jul;42(1):87-95.

PMID:
12830460
49.

Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.

Xu Y, Iyengar S, Roberts RL, Shappell SB, Peehl DM.

J Cell Physiol. 2003 Jul;196(1):131-43.

PMID:
12767049
50.

Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.

Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ.

Cancer Res. 2003 May 1;63(9):2256-67.

Supplemental Content

Loading ...
Support Center